Red ginseng powder fermented with probiotics exerts antidiabetic effects in the streptozotocin-induced mouse diabetes model

Sun Hee Jang, Jisang Park, Sae Hae Kim, Kyung Min Choi, Eun Sil Ko, Jeong Dan Cha, Young Ran Lee, Hyon Seok Jang, Yong Suk Jang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Context: Red ginseng (heat-processed Panax ginseng) is a well-known alternative medicine with pharmacological antidiabetic activity. It exerts pharmacological effects through the transformation of saponin into metabolites by the intestinal microbiota. Given that intestinal conditions and intestinal microflora vary among individuals, the pharmacological effects of orally administered red ginseng likely may vary among individuals. Objective: To overcome this variation and produce homogeneously effective red ginseng, we evaluated the antidiabetic effects of probiotic-fermented red ginseng in a mouse model. Materials and methods: The antidiabetic efficacy of orally administered probiotic-fermented red ginseng was assessed in ICR mice after induction of diabetes using streptozotocin (170mg/kg body weight). Samples were given orally for 8 weeks, and indicators involved in diabetic disorders such as body weight change, water intake, blood glucose, glucose tolerance and various biochemical parameters were determined. Results: Oral administration of probiotic-fermented red ginseng significantly decreased the level of blood glucose of about 62.5% in the fasting state and induced a significant increase in glucose tolerance of about 10.2% compared to the control diabetic mice. Additionally, various indicators of diabetes and biochemical data (e.g., blood glycosylated haemoglobin level, serum concentrations of insulin, and α-amylase activity) showed a significant improvement in the diabetic conditions of the mice treated with probiotic-fermented red ginseng in comparison with those of control diabetic mice. Discussion and conclusion: Our results demonstrate the antidiabetic effects of probiotic-fermented red ginseng in the streptozotocin-induced mouse diabetes model and suggest that probiotic-fermented red ginseng may be a uniformly effective red ginseng product.

Original languageEnglish
Pages (from-to)317-323
Number of pages7
JournalPharmaceutical Biology
Volume55
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Panax
Probiotics
Streptozocin
Hypoglycemic Agents
Powders
Pharmacology
Blood Glucose
Glucose
Inbred ICR Mouse
Body Weight Changes
Experimental Diabetes Mellitus
Saponins
Glycosylated Hemoglobin A
Amylases
Complementary Therapies
Drinking
Oral Administration
Fasting
Hot Temperature
Body Weight

Keywords

  • Diabetes
  • Fermentation
  • Glucose tolerance
  • Insulin

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine

Cite this

Red ginseng powder fermented with probiotics exerts antidiabetic effects in the streptozotocin-induced mouse diabetes model. / Jang, Sun Hee; Park, Jisang; Kim, Sae Hae; Choi, Kyung Min; Ko, Eun Sil; Cha, Jeong Dan; Lee, Young Ran; Jang, Hyon Seok; Jang, Yong Suk.

In: Pharmaceutical Biology, Vol. 55, No. 1, 01.01.2017, p. 317-323.

Research output: Contribution to journalArticle

Jang, Sun Hee ; Park, Jisang ; Kim, Sae Hae ; Choi, Kyung Min ; Ko, Eun Sil ; Cha, Jeong Dan ; Lee, Young Ran ; Jang, Hyon Seok ; Jang, Yong Suk. / Red ginseng powder fermented with probiotics exerts antidiabetic effects in the streptozotocin-induced mouse diabetes model. In: Pharmaceutical Biology. 2017 ; Vol. 55, No. 1. pp. 317-323.
@article{dbaaa3dbdf014bb9b9e3c04ed0211ef5,
title = "Red ginseng powder fermented with probiotics exerts antidiabetic effects in the streptozotocin-induced mouse diabetes model",
abstract = "Context: Red ginseng (heat-processed Panax ginseng) is a well-known alternative medicine with pharmacological antidiabetic activity. It exerts pharmacological effects through the transformation of saponin into metabolites by the intestinal microbiota. Given that intestinal conditions and intestinal microflora vary among individuals, the pharmacological effects of orally administered red ginseng likely may vary among individuals. Objective: To overcome this variation and produce homogeneously effective red ginseng, we evaluated the antidiabetic effects of probiotic-fermented red ginseng in a mouse model. Materials and methods: The antidiabetic efficacy of orally administered probiotic-fermented red ginseng was assessed in ICR mice after induction of diabetes using streptozotocin (170mg/kg body weight). Samples were given orally for 8 weeks, and indicators involved in diabetic disorders such as body weight change, water intake, blood glucose, glucose tolerance and various biochemical parameters were determined. Results: Oral administration of probiotic-fermented red ginseng significantly decreased the level of blood glucose of about 62.5{\%} in the fasting state and induced a significant increase in glucose tolerance of about 10.2{\%} compared to the control diabetic mice. Additionally, various indicators of diabetes and biochemical data (e.g., blood glycosylated haemoglobin level, serum concentrations of insulin, and α-amylase activity) showed a significant improvement in the diabetic conditions of the mice treated with probiotic-fermented red ginseng in comparison with those of control diabetic mice. Discussion and conclusion: Our results demonstrate the antidiabetic effects of probiotic-fermented red ginseng in the streptozotocin-induced mouse diabetes model and suggest that probiotic-fermented red ginseng may be a uniformly effective red ginseng product.",
keywords = "Diabetes, Fermentation, Glucose tolerance, Insulin",
author = "Jang, {Sun Hee} and Jisang Park and Kim, {Sae Hae} and Choi, {Kyung Min} and Ko, {Eun Sil} and Cha, {Jeong Dan} and Lee, {Young Ran} and Jang, {Hyon Seok} and Jang, {Yong Suk}",
year = "2017",
month = "1",
day = "1",
doi = "10.1080/13880209.2016.1237978",
language = "English",
volume = "55",
pages = "317--323",
journal = "Pharmaceutical Biology",
issn = "1388-0209",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Red ginseng powder fermented with probiotics exerts antidiabetic effects in the streptozotocin-induced mouse diabetes model

AU - Jang, Sun Hee

AU - Park, Jisang

AU - Kim, Sae Hae

AU - Choi, Kyung Min

AU - Ko, Eun Sil

AU - Cha, Jeong Dan

AU - Lee, Young Ran

AU - Jang, Hyon Seok

AU - Jang, Yong Suk

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Context: Red ginseng (heat-processed Panax ginseng) is a well-known alternative medicine with pharmacological antidiabetic activity. It exerts pharmacological effects through the transformation of saponin into metabolites by the intestinal microbiota. Given that intestinal conditions and intestinal microflora vary among individuals, the pharmacological effects of orally administered red ginseng likely may vary among individuals. Objective: To overcome this variation and produce homogeneously effective red ginseng, we evaluated the antidiabetic effects of probiotic-fermented red ginseng in a mouse model. Materials and methods: The antidiabetic efficacy of orally administered probiotic-fermented red ginseng was assessed in ICR mice after induction of diabetes using streptozotocin (170mg/kg body weight). Samples were given orally for 8 weeks, and indicators involved in diabetic disorders such as body weight change, water intake, blood glucose, glucose tolerance and various biochemical parameters were determined. Results: Oral administration of probiotic-fermented red ginseng significantly decreased the level of blood glucose of about 62.5% in the fasting state and induced a significant increase in glucose tolerance of about 10.2% compared to the control diabetic mice. Additionally, various indicators of diabetes and biochemical data (e.g., blood glycosylated haemoglobin level, serum concentrations of insulin, and α-amylase activity) showed a significant improvement in the diabetic conditions of the mice treated with probiotic-fermented red ginseng in comparison with those of control diabetic mice. Discussion and conclusion: Our results demonstrate the antidiabetic effects of probiotic-fermented red ginseng in the streptozotocin-induced mouse diabetes model and suggest that probiotic-fermented red ginseng may be a uniformly effective red ginseng product.

AB - Context: Red ginseng (heat-processed Panax ginseng) is a well-known alternative medicine with pharmacological antidiabetic activity. It exerts pharmacological effects through the transformation of saponin into metabolites by the intestinal microbiota. Given that intestinal conditions and intestinal microflora vary among individuals, the pharmacological effects of orally administered red ginseng likely may vary among individuals. Objective: To overcome this variation and produce homogeneously effective red ginseng, we evaluated the antidiabetic effects of probiotic-fermented red ginseng in a mouse model. Materials and methods: The antidiabetic efficacy of orally administered probiotic-fermented red ginseng was assessed in ICR mice after induction of diabetes using streptozotocin (170mg/kg body weight). Samples were given orally for 8 weeks, and indicators involved in diabetic disorders such as body weight change, water intake, blood glucose, glucose tolerance and various biochemical parameters were determined. Results: Oral administration of probiotic-fermented red ginseng significantly decreased the level of blood glucose of about 62.5% in the fasting state and induced a significant increase in glucose tolerance of about 10.2% compared to the control diabetic mice. Additionally, various indicators of diabetes and biochemical data (e.g., blood glycosylated haemoglobin level, serum concentrations of insulin, and α-amylase activity) showed a significant improvement in the diabetic conditions of the mice treated with probiotic-fermented red ginseng in comparison with those of control diabetic mice. Discussion and conclusion: Our results demonstrate the antidiabetic effects of probiotic-fermented red ginseng in the streptozotocin-induced mouse diabetes model and suggest that probiotic-fermented red ginseng may be a uniformly effective red ginseng product.

KW - Diabetes

KW - Fermentation

KW - Glucose tolerance

KW - Insulin

UR - http://www.scopus.com/inward/record.url?scp=85015004466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015004466&partnerID=8YFLogxK

U2 - 10.1080/13880209.2016.1237978

DO - 10.1080/13880209.2016.1237978

M3 - Article

C2 - 27927080

AN - SCOPUS:85015004466

VL - 55

SP - 317

EP - 323

JO - Pharmaceutical Biology

JF - Pharmaceutical Biology

SN - 1388-0209

IS - 1

ER -